Search

Anna U Bielinska

from Ypsilanti, MI
Age ~70
Get Report
Also known as:
Ann U Bielinska, Anna A, A A
Phone and address:
1652 Golden Ln, Ypsilanti, MI 48198
(734) 487-8623
Connected to:
Claudia R Bielinski, 84Kenneth J Bielinski, 80Maria Bielinski, 59Marianne F Bielinski, 106Martin A Bielinski, 69Mary E Bielinski, 70Stephen H Bielinski, 50Walter M Bielinski, 77Dennis E Bielke, 52Derick M Bielke, 37

Anna Bielinska Phones & Addresses

  • 1652 Golden Ln, Ypsilanti, MI 48198 (734) 487-8623
  • 1652 Golden Ln APT 19, Ypsilanti, MI 48198 (734) 487-8623
  • 1652 Golden Ave, Superior Township, MI 48198 (734) 487-8623
  • Ann Arbor, MI

Resumes

Resumes

Anna Bielinska Photo 1

Research Proffesor

View page
Location:
Ypsilanti, MI
Industry:
Hospital & Health Care
Work:
University of Michigan Medical Center
Research Proffesor
Anna Bielinska Photo 2

Anna Bielinska

View page
Work:
U of M 2007 - 2013
Research Assistant Professor

Publications

Us Patents

Ballistic Transfection With Dendrimers

View page
US Patent:
20040109842, Jun 10, 2004
Filed:
May 8, 2003
Appl. No.:
10/431682
Inventors:
James Baker - Ann Arbor MI, US
Blake Roessler - Ann Arbor MI, US
Anna Bielinska - Ypsilanti MI, US
International Classification:
A61K048/00
C08G063/48
C08G063/91
US Classification:
424/078290, 525/054200
Abstract:
The present invention relates to compositions and methods involving biocompatible dendrimers. In particular, the present invention provides dendrimeric copolymers with poly(propyleneimine) (POPAM) interiors and poly(amidoamine) (PAMAM) exteriors for use in transfection and imaging applications.

Delivery Systems Comprising Biocompatible And Bioerodable Membranes

View page
US Patent:
20040120979, Jun 24, 2004
Filed:
May 30, 2001
Appl. No.:
09/867924
Inventors:
Blake Roessler - Ann Arbor MI, US
James Baker - Ann Arbor MI, US
Anna Bielinska - Ypsilanti MI, US
International Classification:
C08G063/91
C08G063/48
A61F002/00
US Classification:
424/426000, 525/054100
Abstract:
The present invention relates to novel compositions and methods for delivering substances to target tissues and cells by contacting the targets with delivery systems associated with membranes (e.g., biocompatible or bioerodable membranes). More particularly, the present invention is directed to dendrimer-based methods and compositions for use in disease therapies, wound healing, and generally, improved gene transfection and compound delivery to target cells and tissues in vitro and in vivo.

Nanoemulsion Vaccines

View page
US Patent:
20060257426, Nov 16, 2006
Filed:
Apr 13, 2006
Appl. No.:
11/403316
Inventors:
James Baker - Ann Arbor MI, US
Anna Bielinska - Ypsilanti MI, US
Andrzej Myc - Ann Arbor MI, US
Assignee:
Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 39/12
A61K 39/21
A61K 39/275
A61K 39/07
US Classification:
424204100, 424234100, 424208100, 424232100, 424246100, 977906000
Abstract:
The present invention provides methods and compositions for the stimulation of immune responses. Specifically, the present invention provides methods and compositions for the use of nanoemulsion compounds as mucosal adjuvants to induce immunity against environmental pathogens. Accordingly, in some embodiments, the present invention provides nanoemulsion vaccines comprising a nanoemulsion and an inactivated pathogen or protein derived from the pathogen. The present invention thus provides improved vaccines against a variety of environmental and human-released pathogens.

Compositions And Methods For Human Immunodeficiency Virus Vaccination

View page
US Patent:
20080026988, Jan 31, 2008
Filed:
Apr 13, 2007
Appl. No.:
11/786855
Inventors:
James Baker - Ann Arbor MI, US
Anna Bielinska - Ypsilanti MI, US
Andrzej Myc - Ann Arbor MI, US
Assignee:
Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 38/16
A61P 31/18
US Classification:
514008000
Abstract:
The present invention relates to methods and compositions for the stimulation of immune responses. Specifically, the present invention provides methods of inducing an immune response to human immunodeficiency virus (HIV) in a subject (e.g., a human subject) and compositions useful in such methods (e.g., a nanoemulsion comprising HIV or antigenic portion thereof).

Compositions And Methods For Orthopox Virus Vaccination

View page
US Patent:
20080038295, Feb 14, 2008
Filed:
Apr 13, 2007
Appl. No.:
11/786860
Inventors:
James Baker - Ann Arbor MI, US
Anna Bielinska - Ypsilanti MI, US
Andrzej Myc - Ann Arbor MI, US
Assignee:
Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 39/275
A61P 31/00
US Classification:
424232100
Abstract:
The present invention relates to methods and compositions for stimulating an immune response. Specifically, the present invention provides methods of inducing an immune response to an orthopox virus (e.g., vaccinia virus) in a subject (e.g., a human subject) and compositions useful in such methods (e.g., a nanoemulsion comprising vaccinia virus). Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination) and research applications.

Nanoemulsion Vaccines

View page
US Patent:
20080181949, Jul 31, 2008
Filed:
Oct 30, 2007
Appl. No.:
11/929295
Inventors:
James R. Baker - Ann Arbor MI, US
Anna Bielinska - Ypsilanti MI, US
Andrzej Myc - Ann Arbor MI, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 9/14
A61P 37/00
A61K 39/00
US Classification:
424484, 4242781, 4242041, 4242341, 4242741
Abstract:
The present invention provides methods and compositions for the stimulation of immune responses. Specifically, the present invention provides methods and compositions for the use of nanoemulsion compounds as mucosal adjuvants to induce immunity against environmental pathogens. Accordingly, in some embodiments, the present invention provides nanoemulsion vaccines comprising a nanoemulsion and an inactivated pathogen or protein derived from the pathogen. The present invention thus provides improved vaccines against a variety of environmental and human-released pathogens.

Compositions And Methods For Orthopox Virus Vaccination

View page
US Patent:
20090068225, Mar 12, 2009
Filed:
Aug 14, 2008
Appl. No.:
12/191688
Inventors:
Anna Bielinska - Ypsilanti MI, US
Andrzej Myc - Ann Arbor MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHGAN - Ann Arbor MI
International Classification:
A61K 39/275
A61P 37/04
US Classification:
4242321
Abstract:
The present invention relates to methods and compositions for stimulating an immune response. Specifically, the present invention provides methods of inducing an immune response to an orthopox virus (e.g., vaccinia virus) in a subject (e.g., a human subject) and compositions useful in such methods (e.g., a nanoemulsion comprising vaccinia virus). Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination) and research applications.

Nanoemulsion Adjuvants

View page
US Patent:
20090291095, Nov 26, 2009
Filed:
May 26, 2009
Appl. No.:
12/472013
Inventors:
Paul E. Makidon - Webberville MI, US
Nicholas J. Mank - Ann Arbor MI, US
Anna U. Bielinska - Ypsilanti MI, US
Assignee:
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 39/00
US Classification:
4241841
Abstract:
The present invention provides methods and compositions for the stimulation of immune responses. In particular, the present invention provides nanoemulsion compositions and methods of using the same for the induction of immune responses (e.g., innate and adaptive immune responses (e.g., for generation of host immunity against an environmental pathogen)). Compositions and methods of the present invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination)) and research applications.
Control profile
Anna U Bielinska from Ypsilanti, MI, age ~70 Get Report